Prostate Cancer in Cisgender Gay and Bisexual Men and Trans Women

Channa A. Amarasekera, MD
Assistant Professor of Urology
Feinberg School of Medicine
Chicago, IL

CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Dr. Amarasekera is an Assistant Professor of Urology at Northwestern University Feinberg School of Medicine with a clinical focus on men’s health, sexual medicine, and reconstructive surgery. He has a special interest in Peyronie’s disease, erectile dysfunction, and prostate cancer survivorship. His research is dedicated to identifying and addressing urologic healthcare disparities faced by sexual minorities. He graduated summa cum laude from the University of Maryland with a degree in Cell Biology and Molecular Genetics and attended Harvard Medical School. He did his residency training at Northwestern. Dr. Amarasekera is the director of the Gay and Bisexual Men’s Urology Program - the nation’s first urology clinic targeting the needs of gay and bisexual men. With Dr. Amarasekera`s leadership, this patient-centered program is designed to improve the urologic care experience, outcomes and quality of life for patients who were assigned male at birth (AMAB) and identify as gay or bisexual.

Learning Objectives: Top of page

At the completion of this educational session, learners will:
1. Learn about the current clinical terminology used to identify sexual minority patients.
2. Know the unique impacts of prostate cancer on gay and bisexual men.
3. Understand how HIV infection influences prostate cancer screening and treatment.

CME Information:Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for April 20, 2022 as a live activity. This activity will also be available as an enduring activity from April 27, 2022, through April 19, 2025. The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

ABIM MOC Recognition Statement:Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to one (1) Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity. - Dr. Braun (Course Director) has no relevant financial relationships to disclose. - Dr. Valenti (Moderator) has no relevant financial relationships to disclose. - Dr. Amarasekera (Presenter) has no relevant financial relationships to disclose. Dr. Amarasekera submitted their slides in advance for adequate peer review, and will support their presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register